by Usha Govindarajulu | Nov 10, 2021 | Biostatistics, Blog, Healtcare, Usha Govindarajulu
Pfizer anti-viral November 10, 2021 Pfizer, similar to Merck, has announced the efficacy of their anti-viral drug called PAXLOVID against SARS-CoV-2. The reported 89% efficacy against serious disease and 100% efficacy against death and they are making headlines....
by Usha Govindarajulu | Aug 6, 2020 | Biostatistics, Blog, Healtcare, New York, Professor, Usha Govindarajulu
Although inflammation isn’t necessarily a good thing, it can help you fight injuries and infections. When this continues for a long period, your body is now fighting chronic inflammation. This condition has been linked to diseases such as diabetes, heart disease, and...
by Usha Govindarajulu | Aug 1, 2020 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As the healthcare industry continues to grow, larger amounts of data are generated every day. All of this data has to be processed, analyzed, and then interpreted by professionals to gain insight. Biostatistics plays a major role in this process as these statistics...
by Usha Govindarajulu | Jul 15, 2020 | Biostatistics, Blog, Epidemiology, Usha Govindarajulu
“Location, location, location”; it matters in so many different aspects of life. But, what role does location play in your health and wellbeing? Can where you live impact your potential to develop certain diseases? The short answer is, yes. In fact, when it comes to...
by Usha Govindarajulu | Jul 13, 2020 | Biostatistics, Blog, Epidemiology, Usha Govindarajulu
As COVID-19 continues to ravage throughout the world, more and more research and studies are being conducted to understand how severe the virus’ impact is, and why it’s severity continues to vary across infected patients. While it’s noted that many infected COVID...
